Panblok H7 with MF59

influenza vaccine H7 subtype with MF59 adjuvant · Sanofi Pasteur

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Panblok H7 with MF59, covering 2025-02-20 to 2025-02-20. Get the full timeline:

Most recent: Clinical Trial Update: Study on Two Adjuvanted Dose Levels of Panblok H7+MF59 Compared for Immunogenicity and Safety With an Unadjuvanted Dose of Panblok H7 in Participants 18 Years of Age and Older [Phase 1, Phase 2]

See pricing